Kim TY - Search Results

1

Serum thyroglobulin testing after thyroid lobectomy in patients with 1-4 cm papillary thyroid carcinoma.

Jang A, Jin M, Kim CA, Jeon MJ, Lee YM, Sung TY, Kim TY, Kim WB, Shong YK, Kim WG. Jang A, et al. Among authors: kim wg, kim ty, kim wb, kim ca. Endocrine. 2023 Aug;81(2):290-297. doi: 10.1007/s12020-023-03346-2. Epub 2023 Mar 13. Endocrine. 2023. PMID: 36913171

2

Epitope heterogeneity of thyroid-stimulating antibodies predicts long-term outcome in Graves' patients treated with antithyroid drugs.

Kim TY, Park YJ, Park DJ, Chung HK, Kim WB, Kohn LD, Cho BY. Kim TY, et al. Among authors: kim wb. J Clin Endocrinol Metab. 2003 Jan;88(1):117-24. doi: 10.1210/jc.2002-020389. J Clin Endocrinol Metab. 2003. PMID: 12519839

3

Ultrasonographic screening for detection of thyroid cancer in patients with Graves' disease.

Kim WB, Han SM, Kim TY, Nam-Goong IS, Gong G, Lee HK, Hong SJ, Shong YK. Kim WB, et al. Among authors: kim ty. Clin Endocrinol (Oxf). 2004 Jun;60(6):719-25. doi: 10.1111/j.1365-2265.2004.02043.x. Clin Endocrinol (Oxf). 2004. PMID: 15163336

4

Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.

Kim ES, Kim TY, Koh JM, Kim YI, Hong SJ, Kim WB, Shong YK. Kim ES, et al. Among authors: kim yi, kim ty, kim wb. Clin Endocrinol (Oxf). 2004 Jul;61(1):145-8. doi: 10.1111/j.1365-2265.2004.02065.x. Clin Endocrinol (Oxf). 2004. PMID: 15212657

5

Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma.

Kim TY, Kim WB, Kim ES, Ryu JS, Yeo JS, Kim SC, Hong SJ, Shong YK. Kim TY, et al. Among authors: kim sc, kim wb, kim es. J Clin Endocrinol Metab. 2005 Mar;90(3):1440-5. doi: 10.1210/jc.2004-1771. Epub 2004 Dec 21. J Clin Endocrinol Metab. 2005. PMID: 15613412

6

Metastasis to the thyroid diagnosed by fine-needle aspiration biopsy.

Kim TY, Kim WB, Gong G, Hong SJ, Shong YK. Kim TY, et al. Among authors: kim wb. Clin Endocrinol (Oxf). 2005 Feb;62(2):236-41. doi: 10.1111/j.1365-2265.2005.02206.x. Clin Endocrinol (Oxf). 2005. PMID: 15670202 Review.

7

Arg16Gly polymorphism in beta2-adrenergic receptor gene is not associated with thyrotoxic periodic paralysis in Korean male patients with Graves' disease.

Kim TY, Song JY, Kim WB, Shong YK. Kim TY, et al. Among authors: kim wb. Clin Endocrinol (Oxf). 2005 May;62(5):585-9. doi: 10.1111/j.1365-2265.2005.02264.x. Clin Endocrinol (Oxf). 2005. PMID: 15853829

8

Systemic inflammatory syndrome and hepatic inflammatory cell infiltration caused by an interleukin-6 producing pheochromocytoma.

Kang JM, Lee WJ, Kim WB, Kim TY, Koh JM, Hong SJ, Huh J, Ro JY, Chi HS, Kim MS. Kang JM, et al. Among authors: kim ty, kim ms, kim wb. Endocr J. 2005 Apr;52(2):193-8. doi: 10.1507/endocrj.52.193. Endocr J. 2005. PMID: 15863947 Free article.

9

18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.

Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK. Kim TY, et al. Among authors: kim wb. Laryngoscope. 2005 Jun;115(6):1074-8. doi: 10.1097/01.MLG.0000163098.01398.79. Laryngoscope. 2005. PMID: 15933524

10

The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma.

Kim TY, Kim WB, Song JY, Rhee YS, Gong G, Cho YM, Kim SY, Kim SC, Hong SJ, Shong YK. Kim TY, et al. Among authors: kim sc, kim sy, kim wb. Clin Endocrinol (Oxf). 2005 Nov;63(5):588-93. doi: 10.1111/j.1365-2265.2005.02389.x. Clin Endocrinol (Oxf). 2005. PMID: 16268813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,571 results

Search Page